Plasma Metabolites for Identifying Bacterial Infection in Acute-on-chronic Liver Failure (IMAGE)
Caption
This study delineated the metabolic landscape of AoCLD associated with bacterial infection. Based on novel metabolite biomarkers, we developed diagnostic models for bacterial infection tailored to the ACLF disease spectrum. These models outperformed conventional indicators. A risk stratification strategy based on baseline metabolic perturbations can indicate the risk of 90-day outcomes. Plasma metabolic biomarkers in these models may serve as reference indicators to enhance precise diagnosis and personalized management in patients with AoCLD.
Credit
Xin Zheng, Lining Guo
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC